
Prescribed Medications and Potential False-Positive Urine ... - Medscape
Subsequent to this report, the manufacturer confirmed the results and included this product in its monoclonal antimethadone antibody screen. [39] No additional reports of false-positive results ...
RH Alloimmunization - Medscape
Oct 16, 2002 · An antibody screen should be performed on every pregnant patient at her first prenatal visit. Although there is some debate, the antibody screen should be repeated at 28 weeks in the Rh …
HLA Antibody Screening and Identification and Their Role in ...
Up to 100 color-coded microspheres can be detected in a single well, thus providing a powerful tool for antibody screening and identification.
HLA Antibody Screening and Identification and Their Role in
The latest developments in antibody assessments and their utilization in transplant testing is discussed.
Certain Antibodies Predict Myositis Better Than Others - Medscape
Jan 30, 2025 · Anti-HMGCR antibodies showed highest predictive value for a myositis diagnosis, followed by anti-MDA5, anti-Jo-1, and anti-TIF1-γ, an analysis of 1068 people with positive myositis …
A Curious Case of Anti-D Antibody Titer - Medscape
Here's an unusual case of an RhD-negative woman who developed a high anti-D antibody titer while pregnant with an RhD-positive fetus despite a negative antibody screen at the time she gave birth.
A Curious Case of Anti-D Antibody Titer - Page 3 - Medscape
Measurement of the amount of anti-D antibody in the plasma is variable between and within laboratories.
Abnormal TSH: Forget it or Fret it? - Medscape
Sep 25, 2024 · I do repeat antibody tests to help gauge if the patient's levothyroxine can be stopped. Medscape: How important is it to follow T4 or T3 levels?
What Factors Predict Thrombosis in aPL Antibody Positivity?
Having a history of thrombosis or hematologic disease was associated with an approximately twofold increased risk for incident thrombosis in patients with persistently positive aPL antibodies.
Trontinemab Rapidly Clears Amyloid With Less ARIA - Medscape
Trontinemab, utilizing Roche’s Brainshuttle technology, boosts drug delivery across the blood-brain barrier, driving robust plaque reduction with low ARIA rates.